http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016046833-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1fda4f6af8e73c9b8c7785ac548dc19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f321663caa70c069651bab3c051194b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_555d1481144634a776ec89114def5961
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 2014-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2130276731fb5648efaf79ad5d7588da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e867bd6a525add7039ee3e301504e1b0
publicationDate 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016046833-A3
titleOfInvention Improved processes for the preparation of agomelatine using novel intermediates
abstract Provided herein are improved, commercially viable and industrially advantageous processes for the preparation of agomelatine, in high yield and purity, using novel intermediates. The process includes: a) reacting N-[2-(7-hydroxy-3,4-dihydro-1-naphthalenyl)ethyl] acetamide with a suitable activating agent; b) subjecting the acylated compound to aromatization by reacting with a suitable aromatizing agent; c) deprotecting the aromatized compound with a suitable deprotecting agent to produce the N-[2-(7-hydroxy-1-naphthalenyl)ethyl] acetamide; d) reacting the deprotected compound with a methylating agent to produce agomeltaine.
priorityDate 2014-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014064706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922771-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7999129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012093402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5420158-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73776375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID240595340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230006683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226486930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11775984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82148

Total number of triples: 27.